Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1949 1
1950 2
1952 2
1955 1
1956 1
1958 2
1960 1
1961 1
1962 2
1963 1
1976 1
1982 1
1987 1
1993 1
1995 2
1996 2
1997 5
1998 1
1999 2
2000 1
2001 2
2002 4
2003 4
2004 3
2005 7
2006 4
2007 3
2008 3
2009 6
2010 6
2011 5
2012 7
2013 10
2014 5
2015 8
2016 3
2017 4
2018 6
2019 10
2020 18
2021 11
2022 14
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
The future of cystic fibrosis care: a global perspective.
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. Bell SC, et al. Among authors: byrnes ca. Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Lancet Respir Med. 2020. PMID: 31570318 Free PMC article. Review.
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
DiPeri TP, Zhao M, Evans KW, Varadarajan K, Moss T, Scott S, Kahle MP, Byrnes CC, Chen H, Lee SS, Halim AB, Hirai H, Wacheck V, Kwong LN, Rodon J, Javle M, Meric-Bernstam F. DiPeri TP, et al. Among authors: byrnes cc. J Hepatol. 2024 Feb;80(2):322-334. doi: 10.1016/j.jhep.2023.10.041. Epub 2023 Nov 14. J Hepatol. 2024. PMID: 37972659
A scoping review of best practices in home enteral tube feeding.
Byrnes C, Mockler D, Lyons L, Loane D, Russell E, Bennett AE. Byrnes C, et al. Prim Health Care Res Dev. 2022 Aug 4;23:e43. doi: 10.1017/S1463423622000366. Prim Health Care Res Dev. 2022. PMID: 35924718 Free PMC article. Review.
Treatment of paediatric non-cystic fibrosis bronchiectasis.
Edwards EA, Twiss J, Byrnes CA. Edwards EA, et al. Among authors: byrnes ca. Expert Opin Pharmacother. 2004 Jul;5(7):1471-84. doi: 10.1517/14656566.5.7.1471. Expert Opin Pharmacother. 2004. PMID: 15212598 Review.
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand.
Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Chang AB, et al. Among authors: byrnes ca. Respirology. 2023 Apr;28(4):339-349. doi: 10.1111/resp.14479. Epub 2023 Mar 2. Respirology. 2023. PMID: 36863703 Free PMC article.
168 results